Improving Cross-Sector Comparisons: Going Beyond the Health-Related QALY

Applied Health Economics and Health Policy

Volumn 13, Issue 6, 2015, Pages 557-565

  Brazier, John ^a   Tsuchiya, Aki ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPARATIVE STUDY; ECONOMIC EVALUATION; ENVIRONMENTAL ECONOMICS; EXPLORATORY RESEARCH; HUMAN; LIFE SATISFACTION; MEDICAL RESEARCH; PSYCHOLOGICAL WELL BEING; QUALITY ADJUSTED LIFE YEAR; RESOURCE ALLOCATION; SOCIAL CARE; VISUAL ANALOG SCALE; WELLBEING; ECONOMICS; FINANCIAL MANAGEMENT; HEALTH SURVEY; SATISFACTION; STANDARDS; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME;

FINANCING, PERSONAL; HEALTH SURVEYS; HUMANS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PERSONAL SATISFACTION; QUALITY IMPROVEMENT; QUALITY-ADJUSTED LIFE YEARS;

EID: 84948571831     PISSN: 11755652     EISSN: 11791896     Source Type: Journal    
DOI: 10.1007/s40258-015-0194-1     Document Type: Article

References (55)

1. Dolan P. Modelling valuations for EuroQol health states. Med Care. 1997;35(11):1095–108.
2. Brazier J, Roberts J, Deverill M. The estimation a preference-based single index measure for health from the SF-36. J Health Econ. 2002;21(2):271–92.
3. Feeny D, Furlong W, Torrance GW, et al. Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Med Care. 2002;40(2):113–28.
4. Wisløff T, et al. Estimating QALY gains in applied studies: a review of cost utility analyses published in 2010. PharmacoEconomics. 2014;32(4):367–75.
5. Brooks R, The EuroQol Group. EuroQol: the current state of play. Health Policy. 1996;37:53–72.
6. Herdman M, Gudex C, Lloyd A. Development and preliminary testing of the new five level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–36.
7. National Institute for Health and Care Excellence (NICE). Guide to the methods of technology appraisal. 2013. http://www.nice.org.uk/article/pmg9/chapter/Foreword. Accessed 23 Aug 2015.
8. Longworth L, Yang Y, Young T, Mulhern B, Hernández Alava M, Mukuria C, Rowen D, Tosh J, Tsuchiya A, Evans P, Keetharuth AD, Brazier J. Use of generic and condition specific measures of Health Related Quality of Life in NICE decision making. Health Technol Assess. 2014;18(9):1–224.
9. Netten A, Burge P, Malley J, Potoglou D, Towers A, Brazier J, Flynn T, Forder J, Wall B. Outcomes of social care for adults: developing a preference weighted measure. Health Technol Assess. 2012;16:1–165.
10. Al-Janabi H, Flynn T, Coast J. A self-report measure of capability well-being for adults: the ICECAP-A. Qual Life Res. 2012;21:167–76.
11. Flynn TN, Huynh E, Peters TJ, Al-Janabi H, Moody A, Clemens S, Coast J. Scoring the ICECAP-A capability instrument. Estimation of a UK general population tariff. Health Econ. 2015. doi:10.1002/hec.3014(online first).
12. Tennant R, Hiller L, Fishwick R, Platt S, Joseph S, Weich S, Parkinson J, Secker J, Stewart-Brown SL. The Warwick–Edinburgh mental well-being Scale (WEMWBS): development and UK validation. Health Qual Life Outcomes. 2007;5(63). ISSN 1477-7525.
13. Office for National Statistics, Harmonised concepts and questions for social data sources: interim harmonised standard—personal well-being. 2014. http://www.ons.gov.uk/ons/guide-method/harmonisation/secondary-set-of-harmonised-concepts-and-questions/index.html. Accessed 23 Aug 2015.
14. Medical research Council. Improving cross-sector comparisons: beyond QALY. 2015. http://www.mrc.ac.uk/funding/how-we-fund-research/highlight-notices/improving-cross-sector-comparisonsbeyond-qaly/. Accessed 23 Aug 2015.
15. Murray CJL, Vos T, Lozano R, Haghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2010;380:2197–223.
16. Salomon JA, Vos T, Hogan DR, Gagnon M, Naghavi M, Mokdad A, Begum N, Shah R, et al. Common values in assessing health outcomes form disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet. 2010;380:2129–43.
17. Gafni A, Birch S. Preferences for outcomes in economic evaluation: an economic approach to addressing economic problems. Soc Sci Med. 1995;40:767–76.
18. Brazier JE, Yang Y, Tsuchiya A, Rowen DL. A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. Eur J Health Econ. 2010;11(2):215–25.
19. Gray A, Rivero-Arias O, Clarke PM. Estimating the association between SF-12 responses and EQ-5D utility values by response mapping. Med Decis Making. 2006;26:18–29.
20. Hernández Alava M, Wailoo A, Ara R. Tails from the peak district: Adjusted Limited Dependent Variable Mixture Models of EQ-5D Health State Utility Values. Value Health. 2012;15(3):550–61. doi:10.1016/j.jval.2011.12.014.
21. Krabbe PFM, Stouthard MEA, Essink-Bot ML, Bonsel GJ. The effect of adding a cognitive dimension to the EuroQol multiattribute health-status classification system. J Clin Epidemiol. 1999;52(4):293–301.
22. Yang Y, Brazier J, Tsuchiya A. Effect of adding a sleep dimension to the EQ-5D descriptive system: A “bolt-on” experiment. Med Decis Making. 2013;34:42–53.
23. Dolan P, Kavetsos G, Tsuchiya A. Sick but satisfied: the impact of health and life satisfaction on choice between health scenarios. J Health Econ. 2013;32(4):708–14.
24. Brazier JE, Ratcliffe J, Tsuchiya A, Solomon J. Measuring and valuing health for economic evaluation. Oxford: Oxford University Press; 2007.
25. Rowen D, Brazier JE, Tsuchiya A, Hernandez M. Valuing states from multiple measures on the same VAS: A feasibility study. Health Econ. 2011;21(6):715–29.
26. Hernández Alava M, Brazier J, Rowen D, Tsuchiya A. Common scale valuations across different preference-based measures: estimation using rank data. Med Decis Making. 2013;33(6):839–52.
27. Dolan P, Kahneman D. Interpretations of utility and their implications for the valuation of health. Econ J. 2008;118(525):215–34.
28. McTaggart-Cowan H. Elicitation of informed general population health state utility values: a review of the literature. Value Health. 2011;14(8):1153–7.
29. Haybron DM. The pursuit of unhappiness: the elusive psychology of Well-being. Oxford: University Press; 2008.
30. Parfit D. Reasons and persons. Oxford: University Press; 1984.
31. Sen A. Commodities and capabilities. Amsterdam: North-Holland; 1985.
32. Nussbaum MC. Sex and Social justice. Oxford: University Press; 1999.
33. Anand P, Hunter G, Carter I, Dowding K, Guala F, van Hees M. The development of capability indicators. J Hum Dev Capab. 2009;10(1):125–52.
34. Burchardt T. Incomes, functionings and capabilities: the well-being of disabled people in Britain. PhD thesis, The London School of Economics and Political Science (LSE); 2005.
35. Dolan P, Lee H, Peasgood T. Losing sight of the wood for the trees: some issues in describing and valuing health, and another possible approach. Pharmacoeconomics. 2012;30(11):1035–49.
36. Mukuria C, Brazier J. Valuing the EQ-5D and the SF-6D health states using subjective well-being: a secondary analysis of patient data. Soc Sci Med. 2012;77:97–105.
37. Stewart-Brown S, Tennant A, Tennant R, Platt S, Parkinson J, Weich S. Internal construct validity of the Warwick–Edinburgh mental well-being scale (WEMWBS): a Rasch analysis using data from the Scottish Health Education Population Survey. Health Qual Life Outcomes. 2009;7:15.
38. Mukuria C, Rowen D, Peasgood T, Brazier J. An empirical comparison of well-being measures used in the UK. Policy Research Unit in economic evaluation of health and care interventions. Universities of Sheffield and York. EEPRU Research Report 027. Policy paper/document 01/04/2015; 2015.
39. Brazier J, Akehurst R, Brennan B, Dolan P, Claxton K, McCabe C, Sculpher M, Tsuchyia A. Should patients have a greater role in valuing health states? Appl Health Econ Policy. 2005;4(4):201–8.
40. Claxton K, Martin S, Soares M, Rice N, Spackman E, Hinde S, Devlin N, Smith PC, Sculpher M. Methods for the estimation of the NICE cost effectiveness threshold. Centre for Health Economics, University of York, CHE research paper 81; 2013.
41. Claxton K, Walker S, Palmer S, Schulpher M. Appropriate perspectives for Health Care Decisions. CHE discussion paper 54, University of York, York, UK; 2010.
42. Department of Health. A new value-based approach to the pricing of branded medicines: a consultation. 2010. http://www.dhsspsni.gov.uk/medicineconsultation.pdf. Accessed 23 Aug 2015.
43. Donaldson C, Mason H, Shackely P. Contingent valuation in health care. In: Jones A, editor. The Elgar companion to health economics. Cheltenham: Edward Elgar; 2006.
44. Boadway RW, Bruce N. Welfare economics. Oxford: Basil Blackwell; 1984.
45. Dixon S, Shackley P. The use of willingness to pay to assess public preferences toward the fortification of foodstuffs with folic acid: results of a pilot study. Health Expect. 2003;6:140–8.
46. Olsen JA, Smith RD. Theory versus practice: a review of ‘willingness-to-pay’ in health and health care. Health Econ. 2001;10(1):39–52.
47. Donaldson C, Shackley P. Does “process utility” exist? A case study of willingness to pay for laparoscopic cholecystectomy. Soc Sci Med. 1997;44(5):699–707.
48. Robinson A, Gyrd-Hansen D, Bacon P, Baker R, Pennington M, Donaldson C. Estimating a WTP-based value of a QALY: the ‘chained’ approach. Soc Sci Med. 2013;92:92–104.
49. Gyrd-Hansen Kjaer, Gyrd-Hansen Dorte, Kjær Trine. Disentangling WTP per QALY data: different analytical approaches, different answers. Health Econ. 2012;21(3):222–37.
50. Kahneman D. Comments on the contingent valuation method. In: Cummings RG, Brookshire DS, Schulze WD, editors. Valuing environmental goods: a state of the arts assessment of the contingent valuation method. Totowa: Roweman and Allanheld; 1986. p. 18–194.
51. McFadden D, Leonard G. Issues in the contingent valuation of environmental goods: methodologies for data collection and analysis. In: Hausman JA, editor. Contingent valuation: a critical assessment. Amsterdam: North Holland; 1993.
52. Kahneman D, Ritov I, Schkade DA. Economic preferences or attitude expressions?: an analysis of dollar responses to public issues. J Risk Uncertain. 1999;19:203–35.
53. Skedgel CD, Wailoo AJ, Akehurst RL. Choosing vs. allocating: discrete choice experiments and constant‐sum paired comparisons for the elicitation of societal preferences. Health Expect. 2013. doi:10.1111/hex.12098.
54. Ferrer-i-Carbonell A, van Praag BMS. The subjective costs of health losses due to chronic diseases. An alternative model for monetary appraisal. Health Econ. 2002;11(8):709–22.
55. Powdthavee N, van Den Berg B. ‘Putting different price tags on the same health problem: re-evaluating the well-being valuation. J Health Econ. 2011;30(5):1032.